Literature DB >> 25599718

Triple antithrombotic therapy in atrial fibrillation patients with acute coronary syndromes or undergoing percutaneous coronary intervention or transcatheter aortic valve replacement.

Davide Capodanno1, Gregory Y H Lip, Stephan Windecker, Kurt Huber, Paulus Kirchhof, Giuseppe Boriani, Deirdre Lane, Martine Gilard, Jean-Philippe Collet, Marco Valgimigli, Robert A Byrne.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25599718     DOI： 10.4244/EIJV10I9A174

Source DB:  PubMed          Journal:  EuroIntervention        ISSN： 1774-024X            Impact factor:   6.534


× No keyword cloud information.
  4 in total

1.  Use of Dual Antiplatelet Therapy and Patient Outcomes in Those Undergoing Percutaneous Coronary Intervention: The ROCKET AF Trial.

Authors:  Matthew W Sherwood; Derek D Cyr; W Schuyler Jones; Richard C Becker; Scott D Berkowitz; Jeffrey B Washam; Günter Breithardt; Keith A A Fox; Jonathan L Halperin; Graeme J Hankey; Daniel E Singer; Jonathan P Piccini; Christopher C Nessel; Kenneth W Mahaffey; Manesh R Patel
Journal:  JACC Cardiovasc Interv       Date:  2016-08-22       Impact factor: 11.195

Review 2.  Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014.

Authors:  Robert A Byrne; Michael Joner; Adnan Kastrati
Journal:  Eur Heart J       Date:  2015-09-28       Impact factor: 29.983

3.  Non-Vitamin K Oral Anticoagulants (NOAC) Versus Vitamin K Antagonists (VKA) for Atrial Fibrillation with Elective or Urgent Percutaneous Coronary Intervention: A Meta-Analysis with a Particular Focus on Combination Type.

Authors:  Ceren Eyileten; Marek Postula; Daniel Jakubik; Aurel Toma; Dagmara Mirowska-Guzel; Giuseppe Patti; Giulia Renda; Jolanta M Siller-Matula
Journal:  J Clin Med       Date:  2020-04-14       Impact factor: 4.241

4.  Safety and Efficacy of Double Antithrombotic Therapy With Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.

Authors:  Davide Capodanno; Marco Di Maio; Antonio Greco; Deepak L Bhatt; C Michael Gibson; Andreas Goette; Renato D Lopes; Roxana Mehran; Pascal Vranckx; Dominick J Angiolillo
Journal:  J Am Heart Assoc       Date:  2020-08-01       Impact factor: 5.501
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.